Vav1 plays an essential role in T cell development and TCR-induced activation, and is required for TCR capping, actin cytoskeleton reorganization, and immunological synapse (IS) formation in T cells. T cells express two additional Vav family members, Vav2 and Vav3, but their precise role in T cell development or activation is unknown. Our past work focused on several aspects of the regulation and function of Vav1 in T cells. We will extend these studies and address several unresolved aspects of the function of Vav in TCR signaling pathways, with increased emphasis on the use of antigen-specific primary T cells and reconstitution studies in Vav-deficient T cells. We will use a combination of biochemical and genetic approaches to analyze Vav-dependent protein-protein interactions and signaling pathways leading to actin cytoskeleton reorganization, CD69 up-regulation, and activation of MAP kinases or transcription factors.
In Aim 1, we will map the physiologically relevant tyrosine phosphorylation sites in Vav1, identify the responsible PTKs, and determine how phosphorylation at different tyrosine residues differentially regulates distinct Vav-induced signals.
In Aim 2, we will explore functional interaction between Vav and the Ras pathway, and attempt to identify signaling components that mediate cross talk between these two pathways.
In Aim 3, we will explore the mechanism that links Vav1 to AP-1 activation by analyzing the role of Vav1 in transcriptional and post-transcriptional events that regulate AP-1 components, with special emphasis on MEF2 transcription factors as potentially novel mediators of Vav1 function.
In Aim 4, we will examine the working hypothesis that actin cytoskeleton reorganization initiated by Vav1 and Rho family GTPase is an important driving force in assembly of the IS and lipid raft clustering. Lastly, in Aim 5, we will analyze the respective roles of Vav1, -2 and -3 in T cell signaling pathways. These studies will clarify the role of Vav1 in different TCRJCD28 signaling pathways, improve our understanding of its regulation and coupling to distinct downstream signaling events, and elucidate the role of Vav2 and Vav3 in T cell activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM050819-11
Application #
6744037
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Marino, Pamela
Project Start
1994-05-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
11
Fiscal Year
2004
Total Cost
$385,400
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Charvet, Celine; Canonigo, Ann Janette; Becart, Stephane et al. (2006) Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J Immunol 177:5024-31
Tanaka, Yoshihiko; So, Takanori; Lebedeva, Svetlana et al. (2005) Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood 106:1286-95
Charvet, Celine; Canonigo, Ann Janette; Billadeau, Daniel D et al. (2005) Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76. J Biol Chem 280:15289-99
Kaminski, S; Del Pozo, M A; Hipskind, R A et al. (2004) Distinct functions of Vav1 in JNK1 activation in Jurkat T cells versus non-haematopoietic cells. Scand J Immunol 59:527-35
del Pozo, Miguel Angel; Schwartz, Martin A; Hu, Junru et al. (2003) Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading. J Immunol 170:41-7
Sedwick, Caitlin E; Altman, Amnon (2002) Ordered just so: lipid rafts and lymphocyte function. Sci STKE 2002:re2
Cao, Youjia; Janssen, Erin M; Duncan, Andrew W et al. (2002) Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. EMBO J 21:4809-19
Villalba, Martin; Bi, Kun; Hu, Junru et al. (2002) Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol 157:253-63
Isakov, Noah; Altman, Amnon (2002) Protein kinase C(theta) in T cell activation. Annu Rev Immunol 20:761-94
Villalba, Martin; Altman, Amnon (2002) Protein kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemias. Curr Cancer Drug Targets 2:125-37

Showing the most recent 10 out of 30 publications